Pallative sedation - An alternative to euthanasia in unbearable pain at the end of life?;Palliative sedierung - Eine alternative zur euthanasie bei unerträglichem leid am ende des lebens?

Medizinische Klinik

Volumn 100, Issue 5, 2005, Pages 292-298

  Weber, Martin ^a   Strohscheer, Imke ^b   Samonigg, Hellmut ^b   Huber, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; LORAZEPAM; PHENOBARBITAL; PROPOFOL;

CANCER; DISTRESS SYNDROME; ETHICS; EUTHANASIA; HUMAN; MEDICAL PRACTICE; MORALITY; PALLIATIVE THERAPY; PSYCHIATRY; QUALITATIVE ANALYSIS; REVIEW; SEDATION; TREATMENT INDICATION;

EID: 20044363988     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-005-1038-9     Document Type: Review

References (61)

1. Abschlussbericht der Bioethikkommission des Landes Rheinland-Pfalz "Sterbehilfe und Sterbebegleitung" vom 23. April 2004. Mainz: Bioethikkommission des Landes Rheinland-Pfalz, 2004:15, 71 (www.cms.justiz.rlp. de).
2. Abschlussbericht der Arbeitsgruppe "Patientenautonomie am Lebensende" am Bundesministerium der Justiz vom 10. 6. 2004. Berlin: Bundesministerium der Justiz, 2004:13, 52 (www.bmj.bund.de/media/archive/695. pdf).
3. Peretti-Watel P, Bendiane MK, Galinier A, et al. French physicians' attitudes toward legalisation of euthanasia and the ambiguous relationship between euthanasia and palliative care. J Palliat Care 2003;19:271-7.
4. Lunshof J. Terminale Sedierung - einige Anmerkungen aus ethischer Sicht zum Tod der Frau K. Z Palliativmed 2002;3:S29.
5. Enck R. Drug-induced terminal sedation for symptom control. Am J Hosp Palliat Care 1991;8:3-5.
6. Chater S, Viola R, Paterson J, et al. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998;12:255-69.
7. Rousseau P. Existential suffering and palliative sedation: a brief commentary with a proposal for clinical guidelines. Am J Hosp Palliat Care 2001;18:151-3.
8. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 2002;24:447-53.
9. Fürst CJ, Hagenfeldt K. [End-of-life sedation - definition and clinical guidelines needed.] Lakartidningen 2002;99:3830-5.
10. Rousseau P. Terminal sedation in the care of dying patients. Arch Intern Med 1996;156:1785-6.
11. Jackson WC. Palliative sedation vs. terminal sedation: what's in a name? Am J Hosp Palliat Care 2002;19:81-2.
12. Braun TC, Hagen NA, Clark T. Development of a clinical practice guideline for palliative sedation. J Palliat Med 2003;6:345-50.
13. Lynch M. Palliative sedation. Clin J Oncol Nurs 2003;7:653-7, 667.
14. Sales JP. Sedation and terminal care. Eur J Palliat Care 2001;8:97-100.
15. Peruselli C, Di Giulio P, Toscani F, et al. Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med 1999;13:233-41.
16. Sykes N, Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 2003;4:312-8.
17. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994;10:31-8.
18. Shaiova L. "Terminal sedation" and existential distress [Case Presentation]. J Pain Symptom Manage 1998; 16:403-4.
19. Cherny NI. Sedation in response to refractory existential distress: walking the fine line [Commentary]. J Pain Symptom Manage 1998;16:404-6.
20. Rosen EJ. A case of "terminal sedation" in the family [Commentary]. J Pain Symptom Manage 1998;16:406-7.
21. Byock IR. When suffering persists ... J Palliat Care 1994;10:8-13.
22. Lanuke K, Fainsinger RL, deMoissac D, et al. Two remarkable dyspneic men: when should terminal sedation be administered? J Palliat Med 2003;6:277-81.
23. Cowan JD, Walsh D. Terminal sedation in palliative medicine - definition and review of the literature. Support Care Cancer 2001;9:403-7.
24. Fainsinger RL, Waller A, Bercovici M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-65.
25. Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie, 4. Aufl. Berlin-Heidelberg-New York-Hongkong-London-Mailand-Paris-Tokio: Springer, 2003.
26. Dickerson D. The 20 essential drugs in palliative care. Eur J Palliat Care 1999;6:130-5.
27. Twycross R, Wilcock A, Charlesworth S, et al. Palliative care formulary, 2 edn. Oxon: Radcliffe Medical Press, 2002.
28. Breitbart W, Chochinov HM, Passik SD. Psychiatric symptoms in palliative medicine. In: Doyle D, Hanks GWC, Cherny NI, et al., eds. Oxford textbook of palliative medicine, 3rd edn. Oxford-New York-Tokyo: Oxford University Press, 2004:746-71.
29. Truog RD, Berde CB, Mitchell C, et al. Barbiturates in the care of the terminally ill. N Engl J Med 1992;327:1678-82.
30. Quill TE, Byock IR. Responding to intractable terminal suffering: the role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 2000;132:408-14.
31. Stirling LC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999;17:363-8.
32. Cheng C, Roemer-Becuwe C, Pereira J. When midazolam fails. J Pain Symptom Manage 2002;23:256-65.
33. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Manage 1995;10:643-6.
34. Soares LG, Naylor C, Martins MA, et al. Dexmedetomidine: a new option for intractable distress in the dying. J Pain Symptom Manage 2002;24:6-8.
35. Muller-Busch HC. Sterbende sedieren? Dtsch Med Wochenschr 2004;129:701-4.
36. Cassell EJ. Diagnosing suffering. Ami Intern Med 1999;131:531-4.
37. Kissane DW. The challenge of discrepancies in values among physicians, patients, and family members. Cancer 2004;100:1771-5.
38. Radbruch L. Reflections on the use of sedation in terminal care. Eur J Palliat Care 2004;9:237-9.
39. Morita T, Akechi T, Sugawara Y, et al. Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: a nationwide survey. J Clin Oncol 2002;20:758-64.
40. Bausewein C, Roller S, Voltz R. Leitfaden Palliativmedizin. München-Jena: Urban & Fischer, 2000.
41. Kristjanson LJ, Sloan JA, Dudgeon D, et al. Family members' perceptions of palliative cancer care: predictors of family functioning and family members' health. J Palliat Care 1996;12:10-20.
42. Jansen LA, Sulmasy DP. Sedation, alimentation, hydration, and equivocation: careful conversation about care at the end of life. Ann Intern Med 2002;136:845-9.
43. Sykes N, Thorns A. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003;163:341-4.
44. Stone P, Phillips C, Spruyt O, et al. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997;11:140-4.
45. Thorns A. A review of the doctrine of double effect. Eur J Palliat Care 1998;5:117-20.
46. Radbruch L, Nauck F, Klaschik E. Sterbehilfe und das Prinzip der Doppelwirkung. Wien Klin Wochenschr 2002;114:878-9.
47. Orentlicher D. The Supreme Court and physician-assisted suicide - rejecting assisted suicide but embracing euthanasia. N Engl J Med 1997;337:1236-9.
48. Billings JA, Block SD. Slow euthanasia. J Palliat Care 1996;12:21-30.
49. Sohn W. [Euthanasia. Open discussion in the context of pain therapy and palliative medicine is also necessary in Germany.] Schmerz 2002;16:150-2.
50. Klein M. Sterbehilfe und das Prinzip der Doppelwirkung. Wien Klin Wochenschr 2002;114:415-21.
51. Loewy EH. Terminal sedation, self-starvation, and orchestrating the end of life. Arch Intern Med 2001;161:329-32.
52. Materstvedt LJ, Clark D, Ellershaw J, et al. Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force. Palliat Med 2003;17:97-101.
53. Morita T, Tsunoda J, Inoue S, et al. Do hospice clinicians sedate patients intending to hasten death? J Palliat Care 1999;15:20-3.
54. Taennsjoe T. Terminal sedation - a possible compromise in the euthanasia debate? Bull Med Ethics 2000;163:13-22.
55. Mount B. Morphine drips, terminal sedation, and slow euthanasia: definitions and facts, not anecdotes. J Palliat Care 1996;12:31-7.
56. Portenoy RK. Morphine infusions at the end of life: the pitfalls in reasoning from anecdote. J Palliat Care 1996;12:44-6.
57. Fuerst CJ, Doyle D. The terminal phase. In: Doyle D, Hanks GWC, Cherny NI, et al., eds. Oxford textbook of palliative medicine, 3rd edn. Oxford-New York-Tokyo: Oxford University Press, 2004:1119-33.
58. Ventafridda V, Ripamonti C, De Conno F, et al. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
59. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994;9:341-5.
60. Fainsinger RL, De Moissac D, Mancini I, et al. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000;16:5-10.
61. Muller-Busch HC, Andres I, Jehser T. Sedation in palliative care - a critical analysis of 7 years experience. BMC Palliat Care 2003;2:3 (http://www.biomedcentral.com/1472-684X/2/2).